ACADIA Pharmaceuticals Inc. - Common Stock — datos financieros trimestrales (NASDAQ:ACAD) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas 40.38 M20.32 M63.96 M74.29 M-48.73 M33.98 M 123.49 M Flujo de caja de las actividades de inversión 122.15 M-124.05 M-43.29 M-79.35 M-55.87 M66.28 M -112.23 M Flujo de caja de las actividades financieras 1.97 M1.84 M15.96 M9.42 M22.67 M4.23 M 52.28 M Flujo de caja libre 40.38 M20.32 M63.96 M73.9 M-52.74 M28.77 M 113.89 M

ACADIA Pharmaceuticals Inc. - Common Stock

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.

Noticias

Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh

MYGN Cancer Care Strategy: What's Driving 2026 Growth Plans

ACADIA Pharmaceuticals Inc. (ACAD) Presents at Bank of America Global Healthcare Conference 2026 Transcript

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Canaccord reitera su calificación de Acadia Pharmaceuticals tras los resultados del primer trimestre

ACADIA Pharmaceuticals presenta resultados: ¿pueden las ventas mantener el impulso?

Diapositivas del Q1 2026 de ACADIA: ingresos suben 11% pese a decepción en beneficios

Acadia Pharmaceuticals (ACAD) Lags Q1 Earnings and Revenue Estimates

ImmunityBio to Report Q1 Earnings: What's in the Cards?

IQVIA Set to Report Q1 Earnings: Here's What You Should Know

Guardian Pharmacy Services to Report Q1 Earnings: What's in the Cards?

CSLLY vs. ACAD: Which Stock Is the Better Value Option?